SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,781.76 -120.83
( -0.16%)

Global Indices

Nasdaq

52,596.82 511.72
(0.98%)

Dow Jones

7,678.62 65.92
(0.87%)

Hang Seng

63,979.83 -1,291.12
(-1.98%)

Nikkei 225

10,650.44 41.52
(0.39%)

Forex

USD-INR

95.45 0.39
(0.41%)

EUR-INR

110.95 0.35
(0.32%)

GBP-INR

129.16 0.36
(0.28%)

JPY-INR

0.62 0.00
(0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gland Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

543245

INE068V01023

655.2871714

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAND

34.14

48214.81

EPS(TTM)

Face Value()

Div & Yield %

85.62

0.68

Back

Rallis India standalone net profit rises 31.58% in the June 2026 quarter

Jul 21,2026

Net profit of Rallis India rose 31.58% to Rs 125.00 crore in the quarter ended June 2026 as against Rs 95.00 crore during the previous quarter ended June 2025. Sales rose 6.79% to Rs 1022.00 crore in the quarter ended June 2026 as against Rs 957.00 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1022.00	957.00	7
OPM %	18.10	15.67	-
PBDT	196.00	158.00	24
PBT	166.00	129.00	29
NP	125.00	95.00	32

74,781.76 -120.83 ( -0.16%)

52,596.82 511.72 (0.98%)

7,678.62 65.92 (0.87%)

63,979.83 -1,291.12 (-1.98%)

10,650.44 41.52 (0.39%)

95.45 0.39 (0.41%)

110.95 0.35 (0.32%)

129.16 0.36 (0.28%)

0.62 0.00 (0.09%)